W
WAVEMAN · COMPANY
OABI · Omniab, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

OABI

OmniAb, Inc.
PHARMA & BIOTECH · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · CIK 0001846253
SEC FILINGS☆ WATCH
INSIDER NET · 180D
-$49.6K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
80
13F, latest reported quarter
REVENUE GROWTH
-
XBRL, annual
NET MARGIN
-
CONVERSIONS · 180D
11
codes C/M, not in net · $0 priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$49.6K over 180 days
more than 58% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
80 funds added or opened last quarter
more than 57% of Pharma & Biotech
REVENUE
no revenue reported in any filing
MARGIN
no margin: this company reports no revenue to divide by
BUYBACKS
no share repurchases reported
SHORT
17.6 days to cover · settled 2026-07-31
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$49.6K across 3 people in 180 days.
80 funds added or opened positions in the latest 13F quarter, of 146 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +174.1%
+174.1%12M
-14%+64%+141%+219%2025-092025-102025-122026-032026-052026-072026-09 2025-11-07 · HIGGINS JOHN L bought $56.6K2026-02-18 · FOEHR MATTHEW W sold $52.7K2025-11-06 · HIGGINS JOHN L bought $51.1K2025-12-08 · GUSTAFSON KURT A sold $46.9K2026-02-17 · FOEHR MATTHEW W sold $35.3K2026-04-07 · FOEHR MATTHEW W sold $28.7K2025-12-08 · FOEHR MATTHEW W sold $26.8K2026-02-18 · Berkman Charles S sold $16.5K2026-02-18 · GUSTAFSON KURT A sold $15.9K2025-12-08 · Berkman Charles S sold $15.8K2026-02-17 · Berkman Charles S sold $11.9K2026-02-17 · GUSTAFSON KURT A sold $11.6K2026-04-07 · Berkman Charles S sold $10.7K2026-04-07 · GUSTAFSON KURT A sold $10.3K
INSIDER BUYINSIDER SELL
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
The record shows a net $49.6K sold by insiders over 180 days, 80 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYELFCITRMDGLDNAVRTXNUVL
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, OmniAb, Inc. insiders sold a net $49.6K of stock across 56 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
FOEHR MATTHEW W
President and CEO
SELL
2026-04-07
19,244.0
$28.7K
GUSTAFSON KURT A
Executive VP, Finance and CFO
SELL
2026-04-07
6,913.0
$10.3K
Berkman Charles S
Chief Legal Officer
SELL
2026-04-07
7,157.0
$10.7K
Berkman Charles S
Chief Legal Officer
SELL
2026-02-18
9,673.0
$16.5K
GUSTAFSON KURT A
Executive VP, Finance and CFO
SELL
2026-02-18
9,301.0
$15.9K
56 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 51 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Whitefort Capital Management, LP
10,248,658.0 sh
$25.2M
BlackRock, Inc.
8,897,490.0 sh
$21.9M
NOMURA HOLDINGS INC
5,028,160.0 sh
$12.4M
CADIAN CAPITAL MANAGEMENT, LP
4,211,821.0 sh
$10.4M
VANGUARD CAPITAL MANAGEMENT LLC
3,852,356.0 sh
$9.5M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Ultra-Small Company Market Fund
$290.4K POSITION · AS OF 2026-03-31
0.2%
Clearwater Select Equity Fund
$371.3K POSITION · AS OF 2026-03-31
0.1%
iShares Micro-Cap ETF
$433.4K POSITION · AS OF 2026-03-31
0.0%
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF
$205.2K POSITION · AS OF 2026-02-28
0.0%
Invesco Nasdaq Biotechnology ETF
$13.9K POSITION · AS OF 2026-02-28
0.0%
1290 VT Micro Cap Portfolio
$30.3K POSITION · AS OF 2026-03-31
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →